Reconsidering NMIHBA Core Features: Macrocephaly Is Not a So Unusual Sign in PRUNE1-Related Encephalopathy

Abstract

PRUNE1-related disorders manifest as severe neurodevelopmental conditions associated with neurodegeneration, implying a differential diagnosis at birth with static encephalopathies, and later with those manifesting progressive brain damage with the involvement of both the central and the peripheral nervous system.

Here we report on another patient with PRUNE1 (p.Asp106Asn) recurrent mutation, whose leukodystrophy, inferior olives hyperintensity, and macrocephaly led to the misleading clinical suspicion of Alexander disease. Clinical features, together with other recent descriptions, suggest avoiding the term “microcephaly” in defining this disorder that could be renamed “neurodevelopmental disorder with progressive encephalopathy, hypotonia, and variable brain anomalies” (NPEHBA).

Keywords

Infantile neurodegeneration - developmental regression - leukodystrophy

^* These authors equally contributed as senior investigators.

Publication History

Received: 10 May 2020

Accepted: 15 June 2020

Article published online:
07 September 2020

• References

• 1 Karaca E, Weitzer S, Pehlivan D. et al; Baylor Hopkins Center for Mendelian Genomics. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell 2014; 157 (03) 636-650
• 2 Zollo M, Ahmed M, Ferrucci V. et al. PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment. Brain 2017; 140 (04) 940-952
• 3 GeneCards®: The Human Gene Database. Available at: https://www.genecards.org/
• 4 Karaca E, Harel T, Pehlivan D. et al. Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic disease. Neuron 2015; 88 (03) 499-513
• 5 Costain G, Shugar A, Krishnan P, Mahmutoglu S, Laughlin S, Kannu P. Homozygous mutation in PRUNE1 in an Oji-Cree male with a complex neurological phenotype. Am J Med Genet A 2017; 173 (03) 740-743
• 6 Alfadhel M, Nashabat M, Hundallah K, Al Hashem A, Alrumayyan A, Tabarki B. PRUNE syndrome is a new neurodevelopmental disorder: report and review. Child Neurol Open 2018; 5: 2329048X17752237
• 7 Alhaddad B, Schossig A, Haack TB. et al. PRUNE1 deficiency: expanding the clinical and genetic spectrum. Neuropediatrics 2018; 49 (05) 330-338
• 8 Hartley JN, Simard LR, Ly V, Del Bigio MR, Frosk P. A homozygous canonical splice acceptor site mutation in PRUNE1 is responsible for a rare childhood neurodegenerative disease in Manitoba Cree families. Am J Med Genet A 2019; 179 (02) 206-218
• 9 Iacomino M, Fiorillo C, Torella A. et al. Spinal motor neuron involvement in a patient with homozygous PRUNE mutation. Eur J Paediatr Neurol 2018; 22 (03) 541-543
• 10 Karakaya M, Yilmaz S, Storbeck M. et al. PRUNE1: a disease-causing gene for secondary microcephaly. Brain 2017; 140 (10) e61
• 11 Imagawa E, Yamamoto Y, Mitsuhashi S. et al. PRUNE1-related disorder: expanding the clinical spectrum. Clin Genet 2018; 94 (3-4): 362-367
• 12 Fujii H, Sato N, Takanashi JI. et al. Altered MR imaging findings in a Japanese female child with PRUNE1-related disorder. Brain Dev 2020; 42 (03) 302-306
• 13 Camfield P, Camfield C. Regression in children with epilepsy. Neurosci Biobehav Rev 2019; 96: 210-218
• 14 Poirier K, Saillour Y, Fourniol F. et al. Expanding the spectrum of TUBA1A-related cortical dysgenesis to polymicrogyria. Eur J Hum Genet 2013; 21 (04) 381-385
• 15 Bahi-Buisson N, Poirier K, Fourniol F. et al. LIS-Tubulinopathies Consortium. The wide spectrum of tubulinopathies: what are the key features for the diagnosis?. Brain 2014; 137 (Pt 6): 1676-1700
• 16 Srivatava S, Naidu SAlexander. Disease. In: Adam MP, Ardinger HH, Pagon RA. et al, eds. GeneReviews^® . Seattle (WA): University of Washington, Seattle; 2002
• 17 Tilikete C, Desestret V. Hypertrophic olivary degeneration and palatal or oculopalatal tremor. Front Neurol 2017; 8: 302
• 18 Dobyns WB, Mirzaa GM. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR. Am J Med Genet C Semin Med Genet 2019; 181 (04) 582-590
• 19 Tammenkoski M, Koivula K, Cusanelli E. et al. Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry 2008; 47 (36) 9707-9713
• 20 Herzmann S, Götzelmann I, Reekers LF, Rumpf S. Spatial regulation of microtubule disruption during dendrite pruning in Drosophila . Development 2018; 145 (09) dev156950
• 21 Nordahl CW, Braunschweig D, Iosif AM. et al. Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun 2013; 30: 61-65
• 22 Carotenuto M, Pedone E, Diana D. et al. Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. Sci Rep 2013; 3: 1351